Healthcare -
Biotechnology - NASDAQ - US
$ 20.6
1.73 %
$ 3.5 B
Market Cap
-7.86
P/E
Price Target
Average
144.66%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
35.25%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Immunovant, Inc.
Wall Street analysts predict an average 1-year price target for IMVT of $50.4 , with forecasts ranging from
a
low of
$46 to a high of $57 .
IMVT Lowest Price Target
Wall Street Target
46 USD
123.30%
IMVT Average Price Target
Wall Street Target
50.4 USD
144.66%
IMVT Highest Price Target
Wall Street Target
57 USD
176.70%
REVENUE FORECAST
Revenue Forecast Chart IMVT
EBIT FORECAST
EBIT Forecast Chart IMVT
NET INCOME FORECAST
Net Income Chart IMVT